5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 3.56▲ | 3.56▲ | 3.56▲ | 3.55▲ | 3.23▲ |
MA10 | 3.58▲ | 3.59▲ | 3.56▲ | 3.37▲ | 3.27▲ |
MA20 | 3.57▲ | 3.56▲ | 3.55▲ | 3.24▲ | 16.01▼ |
MA50 | 3.60▲ | 3.42▲ | 3.33▲ | 3.19▲ | 18.49▼ |
MA100 | 3.42▲ | 3.21▲ | 3.20▲ | 18.30▼ | 12.44▼ |
MA200 | 3.22▲ | 3.29▲ | 3.31▲ | 21.35▼ | 9.44▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.001▼ | -0.010▼ | -0.012▼ | 0.249▲ | -1.278▼ |
RSI | 55.599▲ | 57.725▲ | 59.145▲ | 46.816▼ | 33.607▼ |
STOCH | 28.663 | 44.614 | 54.157 | 75.927 | 24.931 |
WILL %R | -36.842 | -31.818 | -44.898 | -23.468▲ | -96.954▼ |
CCI | 33.050 | 75.685 | 56.667 | 115.092▲ | -35.423 |
Tuesday, January 05, 2021 02:13 AM
Calithera Biosciences, Inc. (NASDAQ: CALA) shares dropped 44.6% to close at $2.72 on Monday after the company announced that its CANTATA study of Telaglenastat in Renal Cell Carcinoma did not ...
|
Tuesday, January 05, 2021 01:38 AM
© 2021 Insider Inc. and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service and ...
|
Tuesday, December 08, 2020 11:02 AM
BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) dropped 8.9% to $3.79. MicroStrategy Incorporated (NASDAQ: MSTR) dropped 7.9% to $309.54 after Citigroup downgraded the stock from Neutral to Sell.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/01/21 | 3.62 | 3.62 | 3.62 | 3.62 | 20,792 |
14/01/21 | 3.74 | 3.74 | 3.47 | 3.60 | 350,548 |
13/01/21 | 3.89 | 3.89 | 3.35 | 3.52 | 968,085 |
12/01/21 | 3.26 | 3.86 | 3.20 | 3.75 | 2,204,055 |
11/01/21 | 3.22 | 3.31 | 3.18 | 3.26 | 209,807 |
08/01/21 | 3.36 | 3.37 | 3.14 | 3.25 | 261,508 |
07/01/21 | 3.15 | 3.3567 | 3.12 | 3.29 | 345,139 |
06/01/21 | 3.15 | 3.2281 | 3.00 | 3.10 | 373,816 |
05/01/21 | 3.20 | 3.2182 | 3.02 | 3.10 | 329,911 |
04/01/21 | 2.86 | 3.40 | 2.82 | 3.25 | 1,349,153 |
|
|
||||
|
|
||||
|
|